Indications › Prediabetes › liraglutide
liraglutide in prediabetes
liraglutide is not approved in the US for prediabetes, and has 10 trials on file here in this condition. 7 of them are phase 3 or later. No trial here has a completion date still in the future, so this is a closed body of work rather than an active programme. Being studied in a condition is not the same as being approved for it; most such programmes end without an approval.
10 registered trials study liraglutide (Victoza, Xultophy, Saxenda) in prediabetes. None has a scheduled reporting date on file.
- Trials on file
- 10
- Active
- 0
- Active phase 3
- 0
- Participants in active trials
- 0
- Sponsors
- 9
- Scheduled readouts
- 0
All trials on file
Every registered trial of liraglutide grouped under prediabetes, largest first. Grouping follows the registry’s own condition wording.
See the full record for liraglutide, or every molecule being studied in prediabetes. These are registered trials, nothing more. Most drugs tested in a new condition never get approved for it, and plenty of these will report nothing useful.